Varlilumab (Anti-TNFRSF7 / CD27)

Varlilumab (Anti-TNFRSF7 / CD27) is a human monoclonal antibody with activity against the CD27 receptor. It exhibits potential immunostimulating and antineoplastic activity. MW : 150 KD.
Supplier Selleck Chemicals
Product # A2323
Sku # A2323-1mg
Pricing 1mg, $770.00
Feedback